From 27–30 January 2025, oloBion participated in Arab Health, held at the Dubai World Trade Centre, one of the world’s largest and most influential healthcare exhibitions. The event brings together thousands of healthcare professionals, technology providers, innovators, and decision-makers from across the Middle East and beyond, serving as a key platform for global medical collaboration and innovation.
As part of our international communication and positioning strategy, aligned with our broader innovation and ecosystem activities, oloBion’s participation at Arab Health aimed to reinforce the visibility of our advanced metabolomics, lipidomics and proteomics capabilities and highlight the role of omics technologies at the intersection of nutrition, health, and translational research.
Arab Health provided an international meeting point for life-science and technology stakeholders, enabling discussions around data-driven innovation in nutrition science and translational R&D. During the event, oloBion engaged with biotech companies, research organizations, and innovation teams exploring multi-omics approaches for mechanistic understanding and biomolecular characterization.
At the event, we shared how mass spectrometry and integrated multi-omics workflows can contribute to:
- biomarker discovery and evaluation,
- functional insights into disease-related metabolic pathways across experimental groups,
- and the development of data-driven strategies in precision nutrition and translational research.
Expanding international networks is essential for building future translational collaborations and innovative joint initiatives and we are proud to represent oloBion on the global stage and to contribute to conversations shaping the future of life-science innovation. Events like Arab Health strengthen our commitment to advancing omics-powered solutions that connect scientific rigor with actionable, interpretable insights for R&D decision-making.
If you met us in Dubai and would like to explore collaboration opportunities, we would be delighted to continue the conversation.